Marie Christine Roesch

Research output

Research output per year 2013 2018 2020 2021 2022 2023

• 55 Journal articles
• 10 Scientific review articles
• 1 Chapter
• 1 Editorial

Research output per year

Research output per year

Search results

• 2023

  Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination

  Frantzi, M., Culig, Z., Heidegger, I., Mokou, M., Latosinska, A., Roesch, M. C., Merseburger, A. S., Makridakis, M., Vlahou, A., Blanca-Pedregosa, A., Carrasco-Valiente, J., Mischak, H. & Gomez-Gomez, E., 11.02.2023, In: Cancers. 15, 4, 1166.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Digital Rectal Examination 100%
  • Urine Specimen Collection 97%
  • Mass Spectrometry 69%
  • Prostatic Neoplasms 61%
  • Biomarkers 50%
  3 Citations (Scopus)

• The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemic

  Sehn, F., Büttner, H., Godau, B., Müller, M., Sarcan, S., Offermann, A., Perner, S., Kramer, M. W., Merseburger, A. S. & Roesch, M. C., 02.2023, In: Molecular biology reports. 50, 2, p. 1809-1816 8 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Pandemics 100%
  • Renin-Angiotensin System 97%
  • Prostatic Neoplasms 74%
  • Neoplasms 30%
  • SARS Virus 27%

• The Role of Urine and Washing Cytology in Primary Transurethral Resection of Bladder Tumours

  Struck, J. P., Ozimek, T., Schnoor, M., Offermann, A., Guenther, M., Roesch, M. C., Wießmeye, J. R., Katalinic, A., Perner, S., Borgmann, H., Merseburger, A. S. & Kramer, M. W., 01.09.2023, In: Urologia Internationalis. 107, 8, p. 792-800 9 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Urinary Bladder Neoplasms 100%
  • Cell Biology 90%
  • Urine 74%
  • Cystectomy 8%
  • Urinary Bladder 6%
• 2022

  Advanced delivery of leuprorelin acetate for the treatment of prostatic cancer

  Merseburger, A. S. & Roesch, M. C., 2022, In: Expert Review of Anticancer Therapy. 22, 7, p. 703-715 13 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Leuprolide 100%
  • Acetates 69%
  • Prostatic Neoplasms 56%
  • Androgens 24%
  • Gels 21%

• Comparison of manual and automated digital image analysis systems for quantification of cellular protein expression

  Jagomast, T., Idel, C., Klapper, L., Kuppler, P., Proppe, L., Beume, S., Falougy, M., Steller, D., Hakim, S. G., Offermann, A., Roesch, M. C., Bruchhage, K. L., Perner, S. & Ribbat-Idel, J., 06.2022, In: Histology and Histopathology. 37, 6, p. 527-541 15 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Staining and Labeling 100%
  • Machine Learning 87%
  • Squamous Cell Carcinoma 64%
  • Adenocarcinoma 60%
  • Proteins 56%

• Inhibition of Cyclin-Dependent Kinase 8/Cyclin-Dependent Kinase 19 Suppresses Its Pro-Oncogenic Effects in Prostate Cancer

  Offermann, A., Joerg, V., Becker, F., Roesch, M. C., Kang, D., Lemster, A-L., Behrends, J., Merseburger, A. S., Culig, Z., Sailer, V., Brägelmann, J., Kirfel, J. & Perner, S., 05.2022, In: American Journal of Pathology. 192, 5, p. 813-823 11 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Cyclin-Dependent Kinase 8 100%
  • Cyclin-Dependent Kinases 61%
  • Androgens 47%
  • Prostatic Neoplasms 41%
  • bicalutamide 19%

• Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients

  Mengual, L., Frantzi, M., Mokou, M., Ingelmo-Torres, M., Vlaming, M., Merseburger, A. S., Roesch, M. C., Culig, Z., Alcaraz, A., Vlahou, A., Mischak, H. & Van der Heijden, A. G., 23.11.2022, In: British Journal of Cancer. 127, 11, p. 2043-2051 9 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • peptide 106 100%
  • Urinary Bladder Neoplasms 50%
  • Routine Diagnostic Tests 49%
  • Urine 37%
  • Biomarkers 34%

• Osteoprotektion als Baustein der Therapie des metastasierten Prostatakarzinoms: Behandlungsrealität in Deutschland und Entscheidungspfade zur Therapieoptimierung

  Translated title of the contribution: Osteoprotection in the management of metastatic prostate cancer: Real-world data from Germany and decision guidanceHupe, M. C., Müller, M., Struck, J. P., Wieβmeyer, J. R., Ozimek, T., Steuber, T., Gschwend, J., Hammerer, P., Kramer, M. W. & Merseburger, A. S., 01.02.2022, In: Aktuelle Urologie. 53, 1, p. 43-53 11 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Germany 100%
  • Prostatic Neoplasms 89%
  • Neoplasm Metastasis 46%
  • Castration 41%
  • Bone and Bones 37%

• Targeting cyclin-dependent kinase 7 - association between CDK7 and pMED1 expression in prostate cancer tissue

  Paulsen, F. O., Kang, D., Becker, F., Roth, D., Joerg, V., Dreyer, E., Roesch, M. C., Seidel, C., Merseburger, A. S., Kirfel, J., Sailer, V., Offermann, A. & Perner, S., 01.08.2022, In: Carcinogenesis. 43, 8, p. 779-786 8 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Cyclin-Dependent Kinases 100%
  • Prostatic Neoplasms 67%
  • Mediator Complex Subunit 1 50%
  • Androgen Receptors 45%
  • Transurethral Resection of Prostate 35%
  1 Citation (Scopus)

• The dilemma of 12/14F ureteral access sheath (UAS) usage: a case control study

  Ozimek, T., Wiessmeyer, J. R., Struck, J. P., Roesch, M. C., Gilbert, N., Laturnus, J. M., Merseburger, A. S. & Kramer, M. W., 12.2022, In: BMC Urology. 22, 1, 84.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Ureteroscopy 100%
  • Kidney Calculi 88%
  • Case-Control Studies 59%
  • Lithotripsy 17%
  • Urology 16%

• The Gene Expression Landscape of Prostate Cancer BM Reveals Close Interaction with the Bone Microenvironment

  Saraji, A., Duan, K., Watermann, C., Hempel, K., Roesch, M. C., Krupar, R., Stegmann-Frehse, J., Jonigk, D., Kuehnel, M. P., Klapper, W., Merseburger, A. S., Kirfel, J., Perner, S., Offermann, A. & Sailer, V., 11.2022, In: International Journal of Molecular Sciences. 23, 21, 13029.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Bone Neoplasms 100%
  • Prostatic Neoplasms 64%
  • Gene Expression 48%
  • Bone and Bones 48%
  • Data Curation 41%

• Up-regulation of POM121 is linked to prostate cancer aggressiveness and serves as a prognostic biomarker

  Becker, F., Offermann, A., Roesch, M. C., Joerg, V., Roth, D., Lubczyk, V., Kuefer, R., Sailer, V., Kirfel, J., Merseburger, A. S. & Perner, S., 08.2022, In: Urologic Oncology: Seminars and Original Investigations. 40, 8, p. 380.e11-380.e18

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Prostate Cancer, Hereditary, 7 100%
  • Up-Regulation 45%
  • Biomarkers 40%
  • Prostatic Neoplasms 28%
  • Nuclear Pore Complex Proteins 26%

• Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer

  Frantzi, M., Heidegger, I., Roesch, M. C., Gomez-Gomez, E., Steiner, E., Vlahou, A., Mullen, W., Guler, I., Merseburger, A. S., Mischak, H. & Culig, Z., 09.2022, In: World Journal of Urology. 40, 9, p. 2195-2203 9 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • 2-chloroethyl methyl sulfide 100%
  • Nomograms 55%
  • Prostatic Neoplasms 36%
  • Biomarkers 29%
  • Prostate-Specific Antigen 23%
• 2021

  Analysis of tripartite motif (TRIM) family gene expression in prostate cancer bone metastases

  Offermann, A., Kang, D., Watermann, C., Weingart, A., Hupe, M. C., Saraji, A., Stegmann-Frehse, J., Kruper, R., Schüle, R., Pantel, K., Taubert, H., Duensing, S., Culig, Z., Aigner, A., Klapper, W., Jonigk, D., Philipp Kühnel, M., Merseburger, A. S., Kirfel, J., Sailer, V., & 1 othersPerner, S., 31.12.2021, In: Carcinogenesis. 42, 12, p. 1475-1484 10 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Bone Neoplasms 100%
  • Prostatic Neoplasms 64%
  • Neoplasm Metastasis 50%
  • Gene Expression 48%
  • Tripartite Motif Proteins 37%

• CDK19 as a diagnostic marker for high-grade prostatic intraepithelial neoplasia

  Offermann, A., Joerg, V., Hupe, M. C., Becker, F., Müller, M., Brägelmann, J., Kirfel, J., Merseburger, A. S., Sailer, V., Tharun, L. & Perner, S., 01.11.2021, In: Human Pathology. 117, p. 60-67 8 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Prostatic Intraepithelial Neoplasia 100%
  • Cyclin-Dependent Kinases 81%
  • Prostatic Neoplasms 25%
  • Carcinoma, Intraductal, Noninfiltrating 12%
  • Needle Biopsy 11%

• Comprehensive Nomogram for Prediction of the Uric Acid Composition of Ureteral Stones as a Part of Tailored Stone Therapy

  Wiessmeyer, J. R., Ozimek, T., Struck, J. P., Hupe, M. C., Willig, J., Merseburger, A. S. & Kramer, M. W., 12.02.2021, In: European urology focus.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Nomograms 100%
  • Uric Acid 83%
  • Therapeutics 13%
  • Body Mass Index 11%
  • Urine 11%

• HYAL4-V1/chondroitinase (chase) drives gemcitabine resistance and predicts chemotherapy failure in patients with bladder cancer

  Hasanali, S. L., Morera, D. S., Racine, R. R., Hennig, M., Ghosh, S., Lopez, L. E., Hupe, M. C., Escudero, D. O., Wang, J., Zhu, H., Sarcan, S., Azih, I., Zhou, M., Jordan, A. R., Terris, M. K., Kuczyk, M. A., Merseburger, A. S. & Lokeshwar, V. B., 01.08.2021, In: Clinical Cancer Research. 27, 15, p. 4410-4421 12 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Chondroitinases and Chondroitin Lyases 100%
  • gemcitabine 69%
  • Urinary Bladder Neoplasms 59%
  • Drug Therapy 36%
  • Cytidine Deaminase 21%
  1 Citation (Scopus)

• Intravesikale Gemcitabin-Instillationstherapie bei BCG-Versagen und Mitomycin-Allergie - Der besondere Fall einer Patientin mit invertiertem Papillom der Harnblase

  Translated title of the contribution: Intravesical Gemcitabine instillations following BCG failure and allergy to Mitomycin: A unique case of a patient with an inverted papilloma of the bladderMatzen, M., Offermann, A., Tharun, L., Perner, S., Merseburger, A. S., Kramer, M. & Hupe, M. C., 01.02.2021, In: Aktuelle Urologie. 52, 1, p. 43-46 4 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • mitomycin A 100%
  • Inverted Papilloma 68%
  • Intravesical Administration 63%
  • gemcitabine 51%
  • Mycobacterium bovis 50%

• Risk Factors for a Complicated Postoperative Course in Flexible Ureteroscopy

  Ozimek, T., Hochguertel, L., Hupe, M. C., Struck, J. P., Wiessmeyer, J. R., Gilbert, N., Merseburger, A. S. & Kramer, M. W., 01.06.2021, In: Urologia Internationalis. 105, 7, p. 611-618 8 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Ureteroscopy 100%
  • Systemic Inflammatory Response Syndrome 91%
  • Antibiotic Prophylaxis 24%
  • Urine 14%
  • Logistic Models 13%

• RLC score (R status, lymphovascular invasion, C-reactive protein) predicts survival following radical cystectomy for muscle-invasive bladder cancer

  Struck, J. P., Hupe, M. C., Heinisch, A., Ozimek, T., Hennig, M. J. P., Klee, M., Von Klot, C., Kalogirou, C., Kuczyk, M. A., Merseburger, A. S. & Kramer, M. W., 2021, In: Aktuelle Urologie.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Cystectomy 100%
  • Urinary Bladder Neoplasms 85%
  • C-Reactive Protein 78%
  • Muscles 53%
  • Survival 49%
• 2020

  Adherence to the EAU Guideline Recommendations for Local Tumor Treatment in Penile Cancer: Results of the European PROspective Penile Cancer Study Group Survey (E-PROPS)

  Pallauf, M., Hempel, M. C., Hupe, M. C., May, M., Haccius, M., Weckermann, D., Lebentrau, S., Hoschke, B., Necknig, U., Pfitzenmaier, J., Manka, L., Nuhn, P., Törzsök, P., Lusuardi, L. & Merseburger, A. S., 01.12.2020, In: Advances in Therapy. 37, 12, p. 4969-4980 12 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Penile Neoplasms 100%
  • Guidelines 44%
  • Neoplasms 22%
  • Physicians 14%
  • Therapeutics 11%

• A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer

  Lokeshwar, V. B., Morera, D. S., Hasanali, S. L., Yates, T. J., Hupe, M. C., Knapp, J., Lokeshwar, S. D., Wang, J., Hennig, M. J. P., Baskar, R., Escudero, D. O., Racine, R. R., Dhir, N., Jordan, A. R., Hoye, K., Azih, I., Manoharan, M., Klaassen, Z., Kavuri, S., Lopez, L. E., & 2 othersGhosh, S. & Lokeshwar, B. L., 01.07.2020, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 26, 13, p. 3455-3467 13 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Chondroitinases and Chondroitin Lyases 100%
  • Urinary Bladder Neoplasms 99%
  • Chondroitin Sulfate Proteoglycans 28%
  • Phenotype 18%
  • Neoplasms 16%

• Befundbericht zu Prostatastanzbiopsien – was Pathologen liefern und Urologen wollen

  Translated title of the contribution: Reports of prostate needle biopsies—what pathologists provide and urologists wantOffermann, A., Hupe, M. C., Joerg, V., Sailer, V., Kramer, M. W., Merseburger, A. S., Tharun, L. & Perner, S., 01.04.2020, In: Urologe. 59, 4, p. 461-468 8 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Urologists 100%
  • Pathologists 85%
  • Needles 77%
  • Prostate 72%
  • Biopsy 52%

• Bicentric Retrospective Analysis of en Bloc Resection and Muscularis Mucosae Detection Rate in Non-Muscle Invasive Bladder Tumors: A Real-World Scenario

  Struck, J. P., Kramer, M. W., Katzendorn, O., Hupe, M. C., Ozimek, T., Hennig, M. J. P., Wießmeyer, J. R., von Klot, C. A. J., Kuczyk, M. A., Kreipe, H. H., Merseburger, A. S., Perner, S. & Dressler, F. F., 22.10.2020, In: Advances in Therapy.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Urinary Bladder Neoplasms 100%
  • Mucous Membrane 83%
  • Tissue Preservation 13%
  • Neoplasms 12%

• Checkpoint Inhibition for Metastatic Urothelial Carcinoma After Chemotherapy—Real-World Clinical Impressions and Comparative Review of the Literature

  Fuhrmann, C., Struck, J. P., Ivanyi, P., Kramer, M. W., Hupe, M. C., Hensen, B., Fürschke, A., Peters, I., Merseburger, A. S., Kuczyk, M. A. & von Klot, C. A. J., 21.05.2020, In: Frontiers in Oncology. 10, 808.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Carcinoma 100%
  • Progression-Free Survival 34%
  • Survival 31%
  • atezolizumab 29%
  • pembrolizumab 26%

• Hemopatch^® as a Hemostatic Agent is Safe in Partial Nephrectomy: A Large, Single-Surgeon Retrospective Evaluation

  Hupe, M. C., Büttner, M., Tabrizi, P. F., Merseburger, A. S., Kuczyk, M. A. & Imkamp, F., 04.12.2020, In: Advances in Therapy.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Hemostatics 100%
  • Nephrectomy 94%
  • Surgeons 67%
  • Hemorrhage 20%
  • Kidney 16%

• Histomorphological analysis of false positive PI-RADS 4 and 5 lesions

  Hupe, M. C., Offermann, A., Tharun, L., Fürschke, A., Frydrychowicz, A., Garstka, N., Shariat, S. F., Barkhausen, J., Merseburger, A. S., Kramer, M. W. & Perner, S., 01.07.2020, In: Urologic Oncology: Seminars and Original Investigations. 38, 7, p. 636.e7-636.e12

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Biopsy 100%
  • Multiparametric Magnetic Resonance Imaging 69%
  • Prostate 55%
  • Blood Vessels 29%
  • Prostatic Neoplasms 26%

• Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer

  Hupe, M. C., Dormayer, L., Ozimek, T., Struck, J. P., Hennig, M. J. P., Klee, M., Von Klot, C. A. J., Kuczyk, M. A., Merseburger, A. S. & Kramer, M. W., 21.02.2020, In: BMC Cancer. 20, 1, 140.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Urologic Neoplasms 100%
  • Nephrotomy 97%
  • Urinary Bladder Neoplasms 68%
  • Incidence 34%
  • Stents 22%
  1 Citation (Scopus)

• Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancer

  Becker, F., Joerg, V., Hupe, M. C., Roth, D., Krupar, R., Lubczyk, V., Kuefer, R., Sailer, V., Duensing, S., Kirfel, J., Merseburger, A. S., Brägelmann, J., Perner, S. & Offermann, A., 15.01.2020, In: International Journal of Cancer. 146, 2, p. 577-588 12 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Mediator Complex 100%
  • Prostatic Neoplasms 51%
  • Disease-Free Survival 30%
  • Recurrence 24%
  • Castration 24%
  3 Citations (Scopus)

• Laser fibre, rather than the stone, may harm the scope: retrospective monocentric analysis of 26 pre- and intraoperative factors of flexible ureteroscope (fURS) damage

  Ozimek, T., Cordes, J., Gilbert, N., Hupe, M. C., Wiessmeyer, J. R., Schneider, M. H., Merseburger, A. S. & Kramer, M. W., 01.08.2020, In: World Journal of Urology. 38, 8, p. 2035-2040 6 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Ureteroscopes 100%
  • Lasers 53%
  • Ureteroscopy 19%
  • nitinol 18%
  • Kidney Calculi 17%

• New computed tomographic predictors of complicated perioperative course of 17.5F mini-percutaneous nephrolithotomy (mini-PNL)

  Ozimek, T., Laturnus, J. M., Gohlke, C., Wiessmeyer, J. R., Struck, J. P., Hupe, M. C., Merseburger, A. S. & Kramer, M. W., 09.08.2020, In: World Journal of Urology.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Percutaneous Nephrolithotomy 100%
  • Kidney 39%
  • Ribs 23%
  • Urography 12%
  • Skin 11%

• Retrospektive GKV-Versorgungsforschungsstudie über GnRH-Antagonisten/-Agonisten zur initialen Therapie des fortgeschrittenen Prostatakarzinoms - Verordnungsmuster und Krankenhauskosten in Deutschland

  Translated title of the contribution: Retrospective SHI (Statutory Health Insurances) real-world study on initial GnRH antagonist and agonist therapy for advanced prostate cancer: Prescription patterns and hospital costs in GermanyHupe, M. C., Hammerer, P., Ketz, M., Kossack, N., Colling, C. & Merseburger, A. S., 01.06.2020, In: Aktuelle Urologie. 51, 3, p. 275-284 10 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Hospital Costs 100%
  • Health Insurance 91%
  • Gonadotropin-Releasing Hormone 87%
  • Germany 78%
  • Prescriptions 73%

• The Impact of Endourological Experience on Flexible Ureteroscopy Outcomes and Performance at Different Levels of Expertise: Retrospective Multifactorial Analysis

  Ozimek, T., Kramer, M. W., Hupe, M. C., Laturnus, J. M., Struck, J. P., Hennig, M. J. P., Merseburger, A. S. & Cordes, J., 01.06.2020, In: Urologia Internationalis. 104, 5-6, p. 452-458 7 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Ureteroscopy 100%
  • Consultants 78%
  • Kidney Calculi 17%
  • Lasers 11%
  • Equipment and Supplies 8%
• 2019

  Das neue ISUP 2014/WHO 2016 Prostatakarzinom-Grading - Status quo 5 Jahre nach seiner Einführung

  Translated title of the contribution: Status quo 5 years after the introduction of the new ISUP 2014/WHO 2016 prostate cancer grade groupsHupe, M. C., Offermann, A., Sailer, V., Merseburger, A. S. & Perner, S., 2019, In: Aktuelle Urologie. 50, 6, p. 619-624 6 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Prostatic Neoplasms 100%
  • Pathology 79%
  • Neoplasm Grading 56%
  • Medical Overuse 30%
  • PubMed 20%
  1 Citation (Scopus)

• Systemische Chemotherapie beim Urothelkarzinom in Deutschland-Eine Umfrage der Arbeitsgemeinschaften Urologische Onkologie und Internistische Onkologie der Deutschen Krebsgesellschaft e.â ŠV.

  Translated title of the contribution: Practice pattern of systemic therapy for urothelial cancer inâ germanyâ-a survey of the german cancer societyHupe, M. C., Merseburger, A. S., De Wit, M., Rexer, H., Gschwend, J. E. & Krege, S., 2019, In: Tumor Diagnostik und Therapie. 40, 9, p. 600-608 9 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Urinary Bladder Neoplasms 100%
  • Germany 92%
  • Neoplasms 33%
  • Guidelines 33%
  • Intravesical Administration 17%

• The BET-inhibitor PFI-1 diminishes AR/AR-V7 signaling in prostate cancer cells

  Hupe, M. C., Hoda, M. R., Zengerling, F., Perner, S., Merseburger, A. S. & Cronauer, M. V., 12.02.2019, In: World Journal of Urology. 37, 2, p. 343-349 7 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Androgen Receptors 100%
  • Prostatic Neoplasms 73%
  • Transcriptional Activation 14%
  • Quinazolinones 13%
  • Antigen Receptors 9%

• TRIM24 as an independent prognostic biomarker for prostate cancer

  Offermann, A., Roth, D., Hupe, M. C., Hohensteiner, S., Becker, F., Joerg, V., Carlsson, J., Kuempers, C., Ribbat-Idel, J., Tharun, L., Sailer, V., Kirfel, J., Svensson, M., Andren, O., Lubczyk, V., Kuefer, R., Merseburger, A. S. & Perner, S., 09.2019, In: Urologic Oncology: Seminars and Original Investigations. 37, 9, p. 576.e1-576.e10

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Prostatic Neoplasms 100%
  • Biomarkers 82%
  • Needle Biopsy 78%
  • Prostate 60%
  • Recurrence 51%
  6 Citations (Scopus)
• 2018

  Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)

  Nicklas, A. P., Kramer, M. W., Serth, J., Hennenlotter, J., Hupe, M. C., Reimer, D. U., Stenzl, A., Merseburger, A. S., Kuczyk, M. A. & von Klot, C. A. J., 01.11.2018, In: Advances in Therapy. 35, 11, p. 2054-2068 15 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Calgranulin A 100%
  • Urinary Bladder Neoplasms 58%
  • Risk Assessment 50%
  • Recurrence 34%
  • Progression-Free Survival 34%

• Diarrhea and flatulence are major bowel disorders after radical cystectomy: Results from a cross-sectional study in bladder cancer patients

  Hupe, M. C., Vahlensieck, W., Ozimek, T., Struck, J. P., Hennig, M. J. P., Tezval, H., von Klot, C. A., Merseburger, A. S., Kuczyk, M. A. & Kramer, M. W., 01.05.2018, In: Urologic Oncology: Seminars and Original Investigations. 36, 5, p. 237.e1-237.e8

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Flatulence 100%
  • Cystectomy 85%
  • Urinary Bladder Neoplasms 73%
  • Diarrhea 63%
  • Cross-Sectional Studies 49%

• Expression of prostate-specific membrane antigen (PSMA) on biopsies is an independent risk stratifier of prostate cancer patients at time of initial diagnosis

  Hupe, M. C., Philippi, C., Roth, D., Kümpers, C., Ribbat-Idel, J., Becker, F., Joerg, V., Duensing, S., Lubczyk, V. H., Kirfel, J., Sailer, V., Kuefer, R., Merseburger, A. S., Perner, S. & Offermann, A., 01.01.2018, In: Frontiers in Oncology. 8, DEC, 623.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Prostate-Specific Antigen 100%
  • Prostatic Neoplasms 77%
  • Biopsy 59%
  • Membranes 58%
  • Prostatectomy 40%

• Extended Techniques of Minimally Invasive Surgery in the Retroperitoneum: Practice Pattern in German Urology Departments

  Hupe, M. C., Kramer, M. W., Ozimek, T., Merseburger, A. S. & Imkamp, F., 01.10.2018, In: Urologia Internationalis. 101, 3, p. 345-350 6 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Minimally Invasive Surgical Procedures 100%
  • Urology 98%
  • Adrenalectomy 63%
  • Nephrectomy 44%
  • Urologists 12%

• Retrospective analysis of patients with prostate cancer initiating GnRH agonists/antagonists therapy using a German claims database: Epidemiological and patient outcomes

  Hupe, M. C., Hammerer, P., Ketz, M., Kossack, N., Colling, C. & Merseburger, A. S., 01.01.2018, In: Frontiers in Oncology. 8, NOV, 543.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Hormone Antagonists 100%
  • Gonadotropin-Releasing Hormone 73%
  • Prostatic Neoplasms 58%
  • Databases 44%
  • Leuprolide 34%

• Steep infundibulopelvic angle as a new risk factor for flexible ureteroscope damage and complicated postoperative course

  Ozimek, T., Cordes, J., Wiessmeyer, J. R., Schneider, M. H., Hupe, M. C., Gilbert, N., Merseburger, A. S. & Kramer, M. W., 01.07.2018, In: Journal of Endourology. 32, 7, p. 597-602 6 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Ureteroscopes 100%
  • Equipment and Supplies 39%
  • Fluoroscopy 36%
  • Length of Stay 25%
  • Kidney Calculi 19%

• Systemische Chemotherapie beim Urothelkarzinom in Deutschland - Eine Umfrage der Arbeitsgemeinschaften Urologische Onkologie und Internistische Onkologie der Deutschen Krebsgesellschaft e.V.

  Translated title of the contribution: Practice Pattern of Systemic Therapy for Urothelial Cancer in Germany - A Survey of the German Cancer SocietyHupe, M. C., Merseburger, A. S., De Wit, M., Rexer, H., Gschwend, J. E. & Krege, S., 01.01.2018, In: Aktuelle Urologie. 49, 4, p. 346-354 9 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Urinary Bladder Neoplasms 100%
  • Germany 92%
  • Neoplasms 33%
  • Guidelines 33%
  • Intravesical Administration 17%
• 2017

  Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer

  Jordan, A. R., Lokeshwar, S. D., Lopez, L. E., Hennig, M., Chipollini, J., Yates, T., Hupe, M. C., Merseburger, A. S., Shiedlin, A., Cerwinka, W. H., Liu, K. & Lokeshwar, V. B., 01.01.2017, In: Oncotarget. 8, 15, p. 24262-24274 13 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Hyaluronic Acid 100%
  • Antitumor 80%
  • Phosphoinositide 79%
  • Angiogenic 42%
  • Disaccharide 30%
  3 Citations (Scopus)

• Lübecker Konsilkoffer

  Translated title of the contribution: The Lubeck medical consultation bagHupe, M. C., Hennig, M. J. P., Struck, J. P., Salem, J., Merseburger, A. S. & Kramer, M. W., 01.05.2017, In: Urologe. 56, 5, p. 662-664 3 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

• Prognostic value of the new prostate cancer international society of urological pathology grade groups

  Offermann, A., Hohensteiner, S., Kuempers, C., Ribbat-Idel, J., Schneider, F., Becker, F., Hupe, M. C., Duensing, S., Merseburger, A. S., Kirfel, J., Reischl, M., Lubczyk, V., Kuefer, R. & Perner, S., 29.09.2017, In: Frontiers in medicine. 4, SEP, 157.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Prostatectomy 100%
  • Neoplasm Grading 81%
  • Prostatic Neoplasms 77%
  • Pathology 61%
  • Biopsy 44%
  11 Citations (Scopus)

• Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention

  Latosinska, A., Mokou, M., Makridakis, M., Mullen, W., Zoidakis, J., Lygirou, V., Frantzi, M., Katafigiotis, I., Stravodimos, K., Hupe, M. C., Dobrzynski, M., Kolch, W., Merseburger, A. S., Mischak, H., Roubelakis, M. G. & Vlahou, A., 01.01.2017, In: Oncotarget. 8, 41, p. 69435-69455 21 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Prokaryotic Initiation Factor-3 100%
  • Eukaryotic Initiation Factor-3 98%
  • Eukaryotic Initiation Factors 77%
  • Urinary Bladder Neoplasms 54%
  • Proteomics 52%
  2 Citations (Scopus)

• Retrospective Cost Analysis of a Single-Center Reusable Flexible Ureterorenoscopy Program: A Comparative Cost Simulation of Disposable fURS as an Alternative

  Ozimek, T., Schneider, M. H., Hupe, M. C., Wiessmeyer, J. R., Cordes, J., Chlosta, P. L., Merseburger, A. S. & Kramer, M. W., 01.12.2017, In: Journal of Endourology. 31, 12, p. 1226-1230 5 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Costs and Cost Analysis 100%
  • Equipment and Supplies 48%
  • Economics 41%
  • Kidney Calculi 32%
  • Solid-State Lasers 29%
  2 Citations (Scopus)
• 2016

  Successful Pregnancy and Neobladder Subsequent to Muscle Invasive Bladder Cancer and Fertility Preserving Surgery: Case Report and Review of the Literature

  Hupe, M. C., Merseburger, A. S., Günter, H. H., Wüstemann, M. & Von Kaisenberg, C. S., 01.05.2016, In: Urologia Internationalis. 96, 4, p. 488-491 4 p.

  Research output: Journal Articles › Journal articles › Research › peer-review

  • Cystectomy 100%
  • Urinary Bladder Neoplasms 85%
  • Fertility 83%
  • Parturition 61%
  • Carcinoma 58%
  1 Citation (Scopus)